Elijah Weber

Elijah Weber, PhD, is currently the Director of Clinical Pharmacology at AstraZeneca, where they contribute to critical clinical pharmacology efforts for small molecule programs, particularly in inflammation and virology. With over six years of experience, Elijah has previously held positions as a Senior Clinical Pharmacologist and Clinical Pharmacologist at Gilead Sciences, emphasizing their expertise in early-phase clinical development and study design. Elijah earned their degree from the University of Washington between 2012 and 2018 and is committed to ongoing professional growth, including expanding their skills in data visualization and modeling using NONMEM.